ReviewEuropean child & adolescent psychiatry2026
Psychological, social and pharmacological prevention and interventions for young people with emerging, subthreshold or diagnosed personality disorders: A systematic review.
Review in European child & adolescent psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite increasing recognition of personality disorder traits in adolescence, there is currently no systematic review that synthesises evidence across all intervention types and across the full spectrum of personality disorders in young people. This systematic review aims to describe existing psychological, psychosocial and pharmacological prevention and interventions for young people with PDs. Medline, Embase, PsycINFO, and Web of Science were used to retrieve studies. Effective Public Health Practice Project and Critical Skills Appraisal tools was used to assess risk of bias. Studies were included if they examined a prevention or intervention for individuals up to and including the age of 25 years with a PD. Findings were analysed using a narrative synthesis. Overall, forty-three studies were included. Thirteen studies evaluated Dialectical Behaviour Therapy, mostly for borderline PD (BPD), with six reporting significant symptom reductions (p < 0.01). Findings for self-harm and suicidal ideation were mixed. Mentalisation Based Therapy was examined in nine studies, with some evidence of reduced BPD symptoms and self-harm. Interventions such as Metacognitive Interpersonal Therapy (Group)-, Cognitive Analytic Therapy, and Emotion Regulation Training showed promising but inconsistent results. Two randomised controlled trials of omega-3 fatty acids and one of intranasal oxytocin suggested potential benefits, though evidence remains limited. This review suggests that future research should focus on investigating preventions and interventions for dimensional, rather than categorical, forms of PDs in young people. Randomised controlled trials are needed to establish a more robust evidence base for effective treatments.
Indexed as
Identifiers
42047814What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.